BRIEF-Health Canada approves Biopharmx's study of violet iodine
April 4 (Reuters) - Biopharmx Corp
* Health canada approves biopharmx corporation study of violet iodine
* Engages kgk synergize, inc. To manage its canadian phase 4 study for violet molecular iodine breast health supplement Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)
© Thomson Reuters 2017 All rights reserved.